The purpose of the study is to learn if an educational program delivered to parents/guardians can help improve the sleep of children experiencing sleep problems after completing cancer treatment. The name of the intervention is Survivor-SHIP (Sleep Health Information Program).

This study will evaluate Survivor-SHIP in a single-arm trial of 20 off-treatment childhood cancer survivors (ages 5-12). The intervention is an adapted version of the family-centered Sleep Health Program designed at Seattle Children's Hospital. The program offers parents information about how to utilize evidence-based strategies for their child's sleep, and has demonstrated success in a community-based sample of children with behavioral sleep problems. Sessions will focus on providing parents with education about healthy sleep and setting targets for modifiable behaviors that can improve their child's sleep health.

The study will include 3 education sessions taking place over videoconference. Families will be asked to track their child's sleep using sleep diaries during the course of the program. Prior to, and following the program, families will be asked to complete study questionnaires.

Inclusion Criteria:

• Child aged 5-12 years, with a history of a cancer diagnosis (except non-melanoma skin cancer).
• No cancer therapy (excluding chemoprevention) in the past 6 months, and no further therapy planned.
• Child meets diagnostic criteria for insomnia disorder as determined by insomnia screening criteria (see Appendix A)
• Parent/guardian is able to read and write in English.
• Regular access to a computer/smartphone with internet access at home.

Exclusion Criteria:

• Reports child has been diagnosed with a Seizure Disorder or has experienced a seizure in the past 12 months.
• Reports child has been diagnosed with a developmental disorder such as Autism Spectrum Disorder, Cerebral Palsy, Fragile X Syndrome, or Moderate to Profound Intellectual Disability.
• Reports child has been diagnosed with sleep apnea, and are not receiving recommended medical treatment for their sleep apnea.
• Intention to adjust (decrease or increase) child's use of any prescribed or over-the-counter sleep medications during the study period.
• Any impairment (e.g., hearing, visual, cognitive) that interferes with the parent/guardian's ability to complete all study procedures independently.

The Dana-Farber / Harvard Cancer Center encourages and supports the responsible and ethical sharing of data from clinical trials. De-identified participant data from the final research dataset used in the published manuscript may only be shared under the terms of a Data Use Agreement. Requests may be directed to: [contact information for Sponsor Investigator or designee]. The protocol and statistical analysis plan will be made available on Clinicaltrials.gov only as required by federal regulation or as a condition of awards and agreements supporting the research.

Data can be shared no earlier than 1 year following the date of publication

Contact the Belfer Office for Dana-Farber Innovations (BODFI) at innovation@dfci.harvard.edu